Abstract: The present invention relates to a paper or paperboard comprising a polymeric coating, said polymeric coating comprising: a first coating layer attached to the paper or paperboard surface, said first coating layer comprising a blend of: a high density polyethylene (HDPE), medium density polyethylene (MDPE) or linear low density polyethylene (LLDPE), or a mixture thereof, and a low density polyethylene (LDPE); and a second coating layer attached to the first coating layer, said second coating layer consisting essentially of a low density polyethylene (LDPE); wherein the first and second coating layers have a combined grammage of less than 12 g/m2. The present invention relates to a method for manufacturing a polyethylene (PE) coated paper or paperboard substrate.

Abstract: The present invention relates to a process for extrusion coating of a fiber-based substrate, wherein a twin-screw extruder is used on-line in the extrusion coating process.

Abstract: Porous bioabsorbable, bioactive and load-bearing composite medical device structure includes a plurality of regular textile planar layers (1a, 1b . . . ) formed of continuous bioabsorbable polymer matrix and bioceramic fibers acting as reinforcements, both included in continuous fibrous elements (3) forming the textile layers. The layers are placed on top of each other to form a structure having two dimensions (x, y) at right angles to each other according to the two dimensions of the textile layer and a third dimension (z) perpendicular to them and resulting from the piling of the layers. A plurality of passages extend through the layers as a result of the openings (2) defined by portions of the continuous fibrous elements (3) extending substantially in the direction of the plane.

Abstract: A method of enhancing the drug release rate from a composite material. The composite material includes a synthetic, bioabsorbable polymer matrix and a drug particle phase dispersed therein. The release rate of the drug from the polymer matrix is enhanced by orienting the composite material. The drug release rate of the oriented composite material is greater than the drug release rate from an otherwise comparable non-oriented composite material.

Abstract: Porous bioabsorbable, bioactive and load-bearing composite medical device structure includes a plurality of regular textile planar layers (1a, 1b . . . ) formed of continuous bioabsorbable polymer matrix and bioceramic fibers acting as reinforcements, both included in continuous fibrous elements (3) forming the textile layers. The layers are placed on top of each other to form a structure having two dimensions (x, y) at right angles to each other according to the two dimensions of the textile layer and a third dimension (z) perpendicular to them and resulting from the piling of the layers. A plurality of passages extend through the layers as a result of the openings (2) defined by portions of the continuous fibrous elements (3) extending substantially in the direction of the plane.

Abstract: The invention relates to synthetic, bioabsorbable polymer materials and implants, like fibres, sutures, meshes and other tissue management, wound closure or tissue engineering devices, which contain: a) a bioabsorbable polymeric matrix; b) antibiotic and/or anti-inflammatory agent particles or mixture thereof, dispersed in the matrix, and c) optionally an additive agent to facilitate device recognition and/or handling to facilitate the use and application of finalized product. In the matrix, cavities around the particles are induced by mechanical processing of the matrix phase. A preferred embodiment of the present invention is a device (suture) that provides a sustained release of antibiotic agent over several days to several weeks for the prevention or treatment of infection. The sutures may be effectively implanted into or in the vicinity of: 1) infected tissue, 2) potentially infected tissue, or in tissues where infection, should it occur, leads to disastrous consequences.

Abstract: A method of enhancing the drug release rate from a composite material. The composite material includes a synthetic, bioabsorbable polymer matrix and a drug particle phase dispersed therein. The release rate of the drug from the polymer matrix is enhanced by orienting the composite material. The drug release rate of the oriented composite material is greater than the drug release rate from an otherwise comparable non-oriented composite material.

Abstract: A multifunctional biodegradable composite has: a) bioabsorbable polymer matrix phase (M) b) bioabsorbable reinforcing element (R), and c) bioactive tissue/cell reaction modifying agent (TRMA) dispersed in said bioabsorbable matrix phase and selected from the group consisting of anti-inflammatory drugs and statins. Said biodegradable composite may be in a surgical implant capable of acting as a drug-delivery implant.

Abstract: This invention relates to bioabsorbable materials and implants used to prevent and treat infection and promote bone growth. More specifically, this invention relates to synthetic bioabsorbable drug delivery materials and implants comprising: (a) a synthetic bioabsorbable polymeric matrix; (b) an antibiotic phase dispersed into said polymeric matrix; and (c) antibacterial, bioabsorbable, bioactive glass, dispersed into said polymeric matrix for the promotion of bone growth.

Abstract: This invention relates to bioabsorbable materials and implants used to prevent and treat infection and promote bone growth. More specifically, this invention relates to synthetic bioabsorbable drug delivery materials and implants comprising: (a) a synthetic bioabsorbable polymeric matrix; (b) an antibiotic phase dispersed into said polymeric matrix; and (c) antibacterial, bioabsorbable, bioactive glass, dispersed into said polymeric matrix for the promotion of bone growth.

Abstract: The present invention concerns a multilayered polymer film structure, which comprises at least one first layer (1) containing a thermoplastic polymer and at least one second layer (2), arranged adjacent to said first layer, containing a liquid crystalline polymer. According to the invention, the second layer (2) consists essentially of a compounded polymer blend formed by the liquid crystalline polymer and a thermoplastic polymer, the liquid crystalline polymer of the second layer forms a continuous phase, and the first and the second layers (1, 2) contain the same thermoplastic polymer. The oxygen transmission rate of the second layer is less than about 150 cm3/(m2·d·bar), determined according to the standard ASTM D 3985-81, and the water vapour transmission rate of the integral film structure is less than 10 g/(m2·24·h) at RH 80% 23° C., determined according to ASTM F 1249-90. The present structure can be used as a barrier layer in packages.

Abstract: The lamellar layer is formed by overlapping plates of the liquid crystalline polymer in the isotropic matrix. The oxygen transmission rate of a 50 .mu.m thick layer of the monolayer structure is typically less than 150 cm.sup.3 /(m.sup.2 .multidot.d.multidot.bar).

Abstract: A planar porous composite structure including a plurality of regular textile planar layers formed of continuous yarns. The layers are placed on top of each other to form a structure having two dimensions at right angles to each other and a third dimension perpendicular to them and defining a plane having a direction along the two dimensions. A plurality of openings extends through the layers. Each opening is defined by portions of the continuous yarns extending substantially in the direction of the plane and existing in the regular textile planar layers to make the planar layers regular in structure prior to placing them on top of each other. A plurality of passages extends entirely through the structure in a direction substantially perpendicular to the plane of the structure.

Abstract: A method for repairing flow conduits, such as pipe lines, wherein the inner surface of a conduit is provided with a flexible material, including a curing agent as well as a reinforcement layer, and the curing agent is hardened, the reinforcement layer comprising a knitted fabric, wherein the knitted fabric comprises reinforcement filaments which are separate from a fabric-forming yarn and extend inside the knitted fabric substantially in a single direction.